Business Insider -
18 Oct 2017 23:50

Wikimedia Commons The FDA just approved another revolutionary cancer treatment. The treatment, called Yescarta, treats a type of blood cancer called aggressive B-cell non-Hodgkin lymphoma. Thehighly personalized cancer treatment calledCAR T-cell therapy(CAR is short for chimeric antigen receptor) ismade by Kite Pharma, a company that in August was acquired by biotech giant Gilead Sciences. It's a type of cancer immunotherapy, which harnesses the body's immune system to take on cancer cells. In t...
Share this Article
Comment on this Article
Please to comment